The US Medicare program's announcement of a 2.48% payment increase to private insurers for 2027 brings a projected $13 billion in additional funding, positively impacting revenue expectations for managed care companies. However, with technical momentum lacking and sentiment remaining neutral, the market is expected to stay range-bound until clearer catalysts emerge.
